A Randomized, Double-Blind, Placebo-Controlled Trial of Augmentation Topiramate for Chronic Combat-Related Posttraumatic Stress Disorder
Authors:
- Steven E. LindleySLSteven E. Lindley
- Eve B. CarlsonECEve B. Carlson
- Kimberly HillKHKimberly Hill
- 1 December 2007
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Clinical Psychopharmacology
- Vol. 27 (6) , 677-681
Abstract
Topiramate, a novel anticonvulsant, has been reported to rapidly reduce symptoms of posttraumatic stress disorder (PTSD) in an open-label trial. The present study was designed as a test of topiramate's efficacy as adjunctive therapy in a 7-week, randomized, double-blind, placebo-controlled trial. Forty male veterans with PTSD in a residential treatment program were randomized to flexible-dose topiramate or placebo augmentation. The primary outcome measures were PTSD symptom severity and global symptom improvement. Baseline Clinician-Administered PTSD Scale scores were 62.1 +/- 13.9 for placebo and 61.0 +/- 22.2 for topiramate. There was a high dropout rate from the study (55% topiramate; 25% placebo), with 40% of topiramate and 10% of placebo dropping because of adverse events (AEs). No significant treatment effects of topiramate versus placebo were observed for the primary treatment outcomes. Subjects reporting central nervous system-related AEs and with higher baseline severity of depression were more likely to discontinue because of AEs. Primary outcome measures failed to demonstrate a significant effect for topiramate over placebo; however, high dropout rate in the treatment group prohibits definitive conclusions about the efficacy of topiramate in this population.Keywords
This publication has 20 references indexed in Scilit:
- Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trialEuropean Neuropsychopharmacology, 2006
- Substance Use Disorders in Patients With Posttraumatic Stress Disorder: A Review of the LiteratureAmerican Journal of Psychiatry, 2001
- Prevalence of personality disorders among combat veterans with posttraumatic stress disorderJournal of Traumatic Stress, 2000
- Divalproex in posttraumatic stress disorder: An open‐label clinical trialJournal of Traumatic Stress, 1999
- Trauma and Posttraumatic Stress Disorder in the CommunityArchives of General Psychiatry, 1998
- The use of anticonvulsants in posttraumatic stress disorder: Case study and overviewJournal of Traumatic Stress, 1996
- CARBAMAZEPINE FOR PTSDJournal of the American Academy of Child & Adolescent Psychiatry, 1995
- The development of a clinician‐administered PTSD scaleJournal of Traumatic Stress, 1995
- Divalproex in posttraumatic stress disorderAmerican Journal of Psychiatry, 1991
- Preliminary study of carbamazepine in post-traumatic stress disorderPsychosomatics, 1986